Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · IEX Real-Time Price · USD

0.611

-0.001 (-0.23%)

At close: May 31, 2024, 4:00 PM

0.624

+0.013 (2.05%)

After-hours: May 31, 2024, 4:57 PM EDT

Monopar Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Selling, General & Admin	3.23	2.95	2.63	2.44	2.36	Upgrade
Research & Development	5.6	7.59	6.49	4.07	1.97	Upgrade
Operating Expenses	8.83	10.54	9.13	6.51	4.32	Upgrade
Operating Income	-8.83	-10.54	-9.13	-6.51	-4.32	Upgrade
Other Expense / Income	-0.43	-0.02	-0.02	-0.2	-0.1	Upgrade
Pretax Income	-8.4	-10.52	-9.1	-6.3	-4.22	Upgrade
Net Income	-8.4	-10.52	-9.1	-6.3	-4.22	Upgrade
Shares Outstanding (Basic)	14	13	12	11	9	Upgrade
Shares Outstanding (Diluted)	14	13	12	11	9	Upgrade
Shares Change	8.69%	1.98%	13.81%	17.56%	0.32%	Upgrade
EPS (Basic)	-0.61	-0.83	-0.73	-0.58	-0.45	Upgrade
EPS (Diluted)	-0.61	-0.83	-0.73	-0.58	-0.45	Upgrade
Free Cash Flow	-7.86	-7.23	-7.32	-4.66	-3.02	Upgrade
Free Cash Flow Per Share	-0.57	-0.57	-0.59	-0.42	-0.32	Upgrade
EBITDA	-8.4	-10.52	-9.1	-6.3	-4.22	Upgrade
EBIT	-8.4	-10.52	-9.1	-6.3	-4.22	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).